Was told by James Campbell yesterday that data collection and submission remains on track by the March 31 deadline. And there will be no variation to this timeline re: convertible note agreement.
GDelaney, do you think you could post the link to the UBS report on Cephalon/Omapro if it is available? Thanks.
- Forums
- ASX - By Stock
- CXS
- promising biotech
promising biotech, page-5
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online